Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder.
(Q53344714)
scientific article published in June 1999
scientific article published in June 1999
Language:
Current Data About
Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder.
other details
| description | scientific article published in June 1999 |
External Links
| (P356) |
10.4088/JCP.V60N0610
|
| (P698) |
10401920
|